Gene Modulation By Transcription Factor Proteins And Micro RNA In Living Brains After Amphetamine | 8708
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Gene modulation by transcription factor proteins and micro RNA in living brains after Amphetamine

2nd International Conference and Exhibition on Addiction Research & Therapy

Philip K. Liu

Keynote: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.010

This presentation will explore Magnetic Resonance (MR) visible probes to target image intracellular gene transcription activator proteins that are induced by drugs of addiction. Drug addiction is a major health problem that severely hampers the productivity of many members of our society. While studies indicate that drug addiction results from combined influences of genes and environment, recent studies suggest that epigenetic modifications of gene transcription factors may play an important role in the develop\ment of addictions in humans. Advances in cellular and molecular biology in the past century have led to identification of novel gene markers, the signaling pathways they influence and gene activities they regulate. With biopsy the only source of tissue for conventional assays, such studies are not permitted in humans. We will present our effort to develop and investigate a targeted MR imgaing technique and to apply it for studies of drug addiction in a series of live brains. Three such activities that they have shown modification in in studies of drug addiction are intracellular protein coding (messenger RNA) and noncoding (microRNA) and activator protein-1 (AP-1) and nuclear factor kappa-beta (NF-k-b). Our efforts for validation of such technology for gene actions in living brains include using a transgenic mouse that is unable to produce a functional AP-1 protein to bind at the AP-1 site and blocks sensitization of drugs of abuse.
Philip K. Liu has completed his Ph.D. from Michigan State University and postdoctoral studies from the Department of Pathology, University of Washington Medical School. He is an associate biologist and Associate Professor of Radiology at Massachusetts General Hospital and Harvard Medical School. He has published more than 45 peer-reviewed papers in reputed journals.